Part D Coverage Could Lead To Drug Price Uniformity, Pfizer Exec Says
Executive Summary
Implementation of the Medicare Part D drug benefit could ultimately mean more uniform pricing across different market segments in the U.S., a Pfizer exec suggested Jan. 25